清胃方治疗幽门螺旋杆菌相关性胃炎实证的临床观察  

Effect of Qingwei Prescriptions on Helicobacter Pylori Relevant Chronic Gastritis with Excess Syndrome

作　　者：武科选[1] 田耀洲[1] 

机构地区：[1]江苏省中西医结合医院,江苏南京210028

出　　处：《中国医学创新》2014年第30期27-29,共3页Medical Innovation of China

基　　金：江苏省省科技基础设施计划(BM2008152)

摘　　要：目的:探讨清胃方在幽门螺旋杆菌(Hp)相关性胃炎实证治疗中的应临床疗效。方法:选取120例Hp相关性胃炎实证患者,按随机数字表方法分为对照组与观察组各60例。对照组仅给予西药进行治疗,观察组在对照组基础上给予清胃方治疗。比较两组临床疗效、治疗后Hp转阴率。结果:对照组总有效率为83.33%,显著低于观察组的93.33%,差异有统计学意义(P<0.05);对照组治疗后Hp转阴率为86.67%,显著低于观察组的96.67%,差异有统计学意义(P<0.05)。结论:中西医结合疗法在Hp相关性胃炎实证治疗中的临床疗效显著,Hp转阴率较高,值得推广应用。Objective：To observe the effect of Qingwei prescriptions on helicobacter pylori（Hp）relevant chronic gastritis with syndrome of positive.Method：120 patients with Hp relevant chronic gastritis of positive syndrome were selected,They were randomly divide into the observation group and the control group with 60 cases in each. The patients in the two groups were given the same drugs of Western medicine,and the patients in the observation group were given Qingwei prescriptions. Two-week treatment made a course,the effects and negativity turning rate of Hp of the two groups were observed.Result：After the treatment,the total effective rate was 93.33%in the observation group,and 86.33%in the control group,with a statistically significant difference（P〈0.05）.The negativity turning rate of Hp was 96.67%in the observation group,and 86.67%in the control group,the difference of which was statistically significant（P〈0.05）. Conclusion：The therapy of the integrative medicine is of better therapeutic effect to Hp relevant chronic gastritis of positive,is worth popularization and application.

关 键 词：清胃方 HP相关性胃炎 实证 

分 类 号：R259[医药卫生—中西医结合]